Journal of Heart and Lung Transplantation

Papers
(The TQCC of Journal of Heart and Lung Transplantation is 0. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-07-01 to 2025-07-01.)
ArticleCitations
Information for Readers526
Recurrent Migration of a Protekduo Right Ventricular Assist Device: A Case Report348
Utilization of Distressed Communities Index to Examine the Impact of Socioeconomic Status on Left Ventricular Assist Device Outcomes316
Assessing a Conservative Anticoagulation Protocol Following Gastrointestinal Bleeding in Patients with a HeartMate 3 LVAD212
Out-Of-Hospital Cardiac Arrest Donor (OHCAd) Hearts: A Single-Center Experience159
When to Wait, When to Act: A Single-Center Retrospective Review of Patients with Advanced Lung Disease Deemed 'Too Early' to List for Lung Transplantation150
Donor Derived Cell Free DNA is a Reliable Marker in High Risk Heart Transplant Patients118
Pulseless Paradoxus in a Heartmate3 Recipient with Cardiac Tamponade110
Extending the Transplant Practitioner Role within the National Organ Retrieval Team to Include Organ Care Practitioner87
Heart Transplantation Utilizing Organs Following Donation After Circulatory Death (DCD)83
Using Donor Lungs ≥70 Years of Age for Transplantation - Do Long-Term Outcomes Justify the Use?77
(715) Diaphragm Dysfunction from Covid-19 Phrenic Neuropathy: Utilization of Diaphragm Pacing for Recovery72
(849) The Utility of Mechanical Circulatory Support in the Management of Massive Pulmonary Embolism with Right Ventricular Failure71
(797) Implantation from Short Term MCS to Durable VAD: Single Center Experience65
(904) Early Weight Gain During Ex Vivo Lung Perfusion Can Predict Transplant Suitability and Post-Transplant Outcomes64
Predictors of Failure to Rescue After Left Ventricular Assist Device Implantation60
(782) Use of Extracorporeal Membrane Oxygenation in Ranolazine Overdose59
Hemodynamic Modeling for Mitral Regurgitation58
Predictors of One-Year Outcome in Patients Undergoing Cardiac Re-Transplantation: Machine Learning Analysis58
(1033) Effect of Practice Variation Amongst Organ Procurement Organizations on Pediatric Donor Heart Utilization55
Early Mammalian Target of Rapamycin Inhibitor Utilization After Heart Transplantation: Analysis of the UNOS Database53
Polymicrobial and Multiple Blood Stream Infection Episodes as Risk Factors for On-Pump Mortality in Mechanical Circulatory Support Patients50
(811) Incidence of Right Ventricular Dysfunction in Lvad Patients Bridged with High Dose Inotropes48
(908) Does Donor-Recipient Sex Mismatch Have an Influence on Long Term Outcomes after Lung Transplantation? An Experience of a High Volume Center48
(120) Heart Preservation with the Organ Care System in Extended Criteria Donor Hearts: A Single Center Experience47
ISHLT 2023 Author Index46
(1270) Thermal Preconditioning During EVLP Reduces T Lymphocytes and Increases Monocytes and Neutrophils Contents in the Perfusion Solution46
(384) Urine Exosomes for Kidney Health Assessment in Mechanical Circulatory Support46
(151) Plasma Proteomic Signature of Human Heart Transplant Recipients After Restoration of Blood Circulation and Its Relationship to Graft Outcome46
(1153) Characterization of CD3-Guided Anti-Thymocyte Globulin Dose Minimization for Renal Sparing Induction after Heart Transplant43
(742) Prognostic Value of Donor Specific Human Leukocyte Antibodies in Pre-Sensitized Heart Transplant Patients43
Challenges in Heart Transplantation During COVID-19 Pandemic in Brazil42
Use of a Medication Questionnaire to Identify Lung Transplant Recipients Benefiting from Pharmacist Prioritization in Clinic41
(1206) Clinical Implications of Microbiome on Acute Rejection in Lung Transplant Recipients41
(1188) Assessment of Dd-cfDNA Between Stable Single and Double Lung Recipients41
(1226) Serum Proteomics for Fibrotic Markers in Early Detection of Bronchiolitis Obliterans Syndrome after Lung Transplantation39
(1215) Think Inside The Box: Constrictive Pericarditis after Pediatric Lung Transplant39
(472) Giant Cell Myocarditis with LVAD Presenting with Acute Severe AI Managed with Valve-In-Valve TAVI38
Argon Inhalation Reduces Pulmonary Ischemia-Reperfusion Injury in MHC-inbred CLAWN Miniature Swine38
When a Single Choice Impacts a Single Ventricle: Paracorporeal Pediatric VAD Support at 544 Days37
Pulmonary Hypertension and Diastolic Heart Failure in an Adolescent African-American Cantú Syndrome Patient37
The Normalised Acute Rejection Score in the First Year Post Transplant and Its Association with CLAD37
Hypogammaglobinemia in Patients Palliated with the Fontan Circulation: Implications for Cardiac Transplantation36
(854) Effect of Dobutamine on Rv Contractility and Rv-Pa Coupling in the Normal Rv36
Comparison of LVAD Admissions Before and During the Era of COVID-1936
Sequential Double-Lung Transplantation in Kartagener Syndrome: A Case Report35
Hemodynamic Implications of Sildenafil in Candidates for Heart Transplantation with Group 2 Pulmonary Hypertension: A Single Latin-American Center Registry35
(911) Older Donors in Lung Transplantation: The Portuguese Experience35
Bedside Ultrasound of Internal Jugular Vein for Right Ventricular Function Assessment35
Decoupling Between Pulmonary Artery Diastolic and Wedge Pressure Following TAVR33
Ventricular Arrhythmias and Implantable Cardioverter-Defibrillator Use in Patients with Left-Ventricular Assist Device: Validation of the VT-LVAD Prediction Score33
Safety of Single Lung Transplantation Post Donation Service Area-Specific Organ Distribution33
(888) Initiating an ECMO Program at a Safety Net Hospital During a Global Pandemic32
Kidney Transplantation in Single Ventricle Palliated Patients: A Pediatric Cardiac Care Consortium Study32
Immune Characterization of a Xenogeneic Cross Circulation System for Ex Vivo Human Lung Support31
Impact and Outcomes of Hepatitis C Viremic Donors (HCV-NAAT) on Donor-Derived Cell-Free DNA Levels and Gene-Expresion Profiling (GEP-Allomap) in Heart Transplant Recipients31
Oral Aversion and Its Risks in Pediatric Heart Transplant Recipients31
Title: Clinical Outcomes of Lung Transplant Recipients with Myelodysplastic Syndrome and Short Telomere Syndrome30
Extended Hypothermic Cardiac Preservation Using the VP.S ENCORE® Device Leads to Enhanced Cardiac Function in a Pilot Orthotopic Porcine Heart Transplant Study29
Association of Neighborhood-Level Social Disinvestment with Worse Survival After Lung Transplant is Mediated by Individual Insurance Status29
A High Pulmonary-to-Systemic Arterial Elastance Ratio is a Powerful Predictor of Poor Outcomes After Heart Transplantation: A Clinical Study with Physiological Insights from Digital Twin Models28
Information for Readers28
Disseminated Mycobacterium Tuberculosis Post Lung Transplantation28
Utility of Breath Volatomic Analysis in Lung Transplant Recipients28
Plasma Proteins Ameliorate Loss of Coronary Vascular Resistance During Working Mode Normothermic Ex-Situ Heart Perfusion28
Single Cell Analysis of Bronchiolar Brushings Identifies Basal Cell Loss in CLAD28
Outcomes of Lung Transplantation for Bronchiolitis Obliterans Syndrome After Allogeneic Hematopoietic Stem Cell Transplantation Compared with Interstitial Pulmonary Fibrosis28
Heart Transplant in Transthyretin Cardiac Amyloidosis: A Single-Center Experience28
Not just for the birds: The emerging role of B cells in transplant immunology27
Methods and Preliminary Results of Implementation of Multi-Center Earlyimpella® Support in Patients with St-Segment Elevation Myocardial Infarction Complicated by Cardiogenic Shock (RECOVER IV) Trial 27
Machine Learning Models as an Accurate Predictor of Survival in Pediatric Heart Transplant27
Factors Associated with Prolonged Length of Stay After Pediatric Heart Transplantation27
Correlation Between Donor-Specific Antibodies and Molecular Microscope Results in Heart Transplant Recipients27
Lung Transplant Using Extra-Corporeal Membrane Oxygenation: Outcomes and Predictors of Conversion to Cardiopulmonary Bypass26
Micro-RNA Biomarkers of Allograft Rejection in Pediatric Heart Transplantation26
Evaluation of Pulmonary Vasodilator Efficacy in LVAD Patients Using Invasive Right Heart Catheter Stress Testing26
Waitlist Mortality for Patients with Cardiac Allograft Vasculopathy Under the 2018 UNOS Donor Heart Allocation System26
Hepatitis B Virus Reactivation in Lung Transplant Recipients with Previous Resolved Infection25
Early Onset Malignancy in the First-Year After Heart Transplantation25
Older Donor Hearts for Heart Transplantation25
Comparison Between Waiting List Diagnosis for Lung Transplantation for Pulmonary Interstitial Disease and Explant Analysis from the Largest Lung Transplantation Group of Brazil25
WITHDRAWN25
Long Term Use of Implantable Left Ventricular Assist Devices in Pediatric Patients25
Genome-Wide DNA Methylation Profiling in Human Dilated Cardiomyopathy25
Impact of Preoperative Left Ventricular Ejection Fraction on Outcomes After Pulmonary Thromboendarterectomy for Chronic Thromboembolic Pulmonary Hypertension25
Editorial Board24
Comparative Analysis of Fontan Transplant Outcomes24
Organ Care System (OCS) Perfusion Time During Donation After Circulatory Death (DCD) Heart Transplantation: Not Too Little, Not Too Much: There Safety Lie23
Extent of Pulmonary Vascular Resistance Reduction with Temporary Mechanical Circulatory Devices Among Patients Awaiting Cardiac Transplantation23
Living-Donor Single-Lobe Lung Transplantation: A Single-Center Case Series23
Safety of Erythropoiesis-Stimulating Agents for Pediatric Berlin EXCOR VAD Patients23
Amyloid Unmasked: A Rare Case of Apolipoprotein A- IV Cardiac Amyloidosis23
Evaluation of Platelet Activation by Flow Cytometry in Contemporary Continuous Flow Left Ventricular Assist Device Support23
Table of Contents23
Exercise Test and Hemodynamic Outcomes in Heart Transplant Patients Treated with Long-Term Mechanical Circulatory Support as Bridge to Transplantation23
Cardiac Tamponade Associated to an Early EBV-Induced Lymphoma After Heart Transplantation: A Case Report22
Imaging Mass Cytometry for Detailed Cellular and Spatial Characterization of Chronic Lung Allograft Dysfunction (CLAD)22
Do Temporary Mechanical Circulatory Support Devices Activate Sensitization Pathways in Patients Awaiting Heart Transplantation?22
Lactic Acid and Metabolic Analysis of Human Donor Hearts Preserved with Organ Care System22
Ex-vivo lung perfusion: National trends and post-transplant outcomes22
MTHFD2 ablation in T cells protects against heart transplant rejection by perturbing IRF4/PD-1 pathway through the metabolic-epigenetic nexus22
Kidney function assessment using cystatin C and serum creatinine in heart transplantation recipients: Implications for valganciclovir dosing22
Primary graft dysfunction, dysbiosis, and innate immune activation after lung transplantation22
Recurrence of pulmonary arterial hypertension 32 months after bilateral lung transplant22
The impact of cardiovascular and lung comorbidities in patients with pulmonary arterial hypertension: A systematic review and meta-analysis22
Going the distance: Long-term follow-up of the randomized, prospective Scandinavian heart transplant everolimus de novo study with early calcineurin inhibitors avoidance (SCHEDULE) trial22
Lung Transplantation from hepatitis C+ donor lungs: Reassuring midterm outcomes21
Normothermic Ex Vivo Lung Perfusion (Novel) as an Assessment of Extended Criteria Donor Lungs: A Prospective Multi-Center Clinical Trial21
Evaluating age-based eligibility thresholds for heart re-transplantation – an analysis of the united network for organ sharing database21
Extra-cardiac management of cardiogenic shock in the intensive care unit21
Lung transplantation following donation after thoraco-abdominal normothermic regional perfusion (TA-NRP): A feasibility case study21
Alveolar macrophage subsets: Accessories to lung alloimmune rejection21
Functional status predicts pediatric heart transplant outcomes: A united network for organ sharing (UNOS) database study21
Pediatric Heart Transplantation in Donation After Circulatory Death Using Normothermic Regional Perfusion - Early Experience with Small Donors20
Pseudomonas-dominant microbiome elicits sustained IL-1β upregulation in alveolar macrophages from lung transplant recipients20
Cardiac output assessment methods in left ventricular assist device patients: A problem of heteroscedasticity20
Impact of Logistic Challenges on Cardiac Transplantation20
Blockade of BLyS inhibits B-cell responses and antibody production for the prevention of chronic transplant rejection20
Sotrovimab in pediatric cardiac transplant recipients with SARS-CoV2 infection20
Daratumumab monotherapy as a desensitization strategy prior to cardiac transplantation20
The human cytomegalovirus-specific and UL40-mediated imprint in the natural killer cell repertoire is associated with antibody-mediated rejection in lung transplant recipients20
What's in a name: The importance of lung transplant at Cystic Fibrosis Foundation Accredited Care Centers for patients with Cystic Fibrosis20
Social Determinants of Health, Race and Their Relationship to Time in Therapeutic INR Range Following LVAD Implantation20
Comparing the Outcomes of Combined Heart-Liver Transplant Recipients from DCD and Non-DCD Donors: An Analysis Using the UNOS Database19
Backwash Maneuver in LVAD Inflow Thrombosis: A Single-Center Experience (2015-2024)19
New Rules, Improved Results: Successful Outcomes Bridging Patients Listed Status 1 for Heart Transplantation19
Lung Transplantation for Primary Ciliary Dyskinesia - A Single Center Review19
Early Detection of Baseline Lung Allograft Dysfunction: The Concept of Pre-BLAD19
Duration of Donor Cardiac Downtime in Donors After Circulatory Death Transplant19
Improved Oxygenation and Atelectasis in Brain-Dead (BD) Donors with a Novel Percutaneous Transvenous Phrenic Nerve Stimulator19
Enhancing Post-Lung Transplant Care with AlloHome: Early Impact Evaluation19
Survival After Combined Lung and Liver Transplantation: A 22-year Single-Centre Retrospective Study19
Cold Blood Cardioplegia Use for Cardiac Arrest After Heart Transportation with Organ Care System May Improve Outcomes18
Single Nuclei Transcriptomic Analysis of Heart Allograft Ischemia-Reperfusion in a Rat Model18
Center volume effect on acute cellular rejection and outcomes in pediatric lung transplant recipients18
Influence of Risk Factors on PTLD-Free Probability in Lung Transplant Patients: SRTR Database Analysis18
Donor heart ischemic time can be extended beyond 9 hours using hypothermic machine perfusion in sheep18
Use of Heart in Donor Death Caused by Lightning18
Outcomes After Heart Transplantation from Donors After Circulatory Death versus Brain Death: A Systematic Review and Meta-Analysis17
A Bold Look: Evaluation of Skeletal Muscle Microvascular Function in Pediatric Heart Transplant Recipients Using Post-Contractile Blood Oxygen Level Dependent MRI17
Hemodynamic Effects of Impella 5.5 in Cardiogenic Shock and Acute Decompensated Heart Failure17
Outcomes in Children Supported with Paracorporeal Continuous Compared to Paracorporeal Pulsatile Ventricular Assist Devices17
Letermovir Use for Cytomegalovirus Prophylaxis in Lung Transplant Recipients17
A Single Centre Review of INR Monitoring in Patients Implanted with HeartMate 3 Ventricular Assist Device17
Midterm Outcomes in Orthotopic Heart Transplant Recipients with a History of Methamphetamine Use17
Global Outcomes with Extended Criteria Donors When Preserved at 4-8°C: An Updated Analysis of the International GUARDIAN Heart Registry17
Immunologic Outcomes Following Mycophenolate Dose Reduction in Lung Transplant Recipients17
Mollicute Infections in Lung Transplant Patients: A Retrospective Review of Recipient Infections Post Initiation of a Screening Protocol17
End Stage Heart Failure in Systemic Sclerosis- From Mechanical Circulatory Support to Heart Transplant17
Donor Factors Contributing to the Increase in Adult Heart Transplant Volume in the United States17
Conversion from Immediate Release Tacrolimus to LCP-Tacrolimus in Heart Transplant Recipients17
SRC Homology and Collagen (Shc) Inhibition: A Novel Therapeutic Strategy for Transplant-Related Pulmonary Fibrosis16
Pharmacist Managed Timing of Peri-Operative Plasmapheresis and Anti-Thymocyte Globulin in Heart Transplantation16
Impact of Donor Transfusions on Lung Transplant Outcomes: A National Cohort Analysis16
The evaluation of constant coronary artery flow versus constant coronary perfusion pressure during normothermic ex situ heart perfusion16
Recipient and surgical factors trigger severe primary graft dysfunction after heart transplant16
DCD Heart Transplantation with NRP: Excellent Results and a Continued Uphill Battle16
Effect of Heparin Coated ECMO Circuit on AntiPF4 Antibodies16
Acute Myocarditis: Trying to Dissect Potential Prognostic Factors16
An Uncommon Driver of Waitlist Urgency: Recurrent Secondary Spontaneous Pneumothoraces of the Lung Allograft in a Single Lung Transplant (SLT) Recipient with CLAD16
Post Transplant Malignancy Risk Factors in Thoracic Solid Organ Transplant Recipients16
Determining the impact of ex-vivo lung perfusion on hospital costs for lung transplantation: A retrospective cohort study16
Risk stratification in patients with pulmonary arterial hypertension at the time of listing for lung transplantation16
Extending the Bridge, Bridging the Gap16
Early Outcomes from the Use of Thoracic Epidural Analgesia versus INC Cryoablation during Lung Transplantation - A Single Center Experience16
Sternal Closure After Clamshell Thoracotomy for Bilateral Lung Transplantation: Comparison Between Different Techniques16
The Use of Ambulatory Blood Pressure Monitoring in Pediatric Heart Transplant Recipients16
Activation of cGAS-Dependent Necroptosis during Cold Static Preservation of Lungs Relies on Calcium16
(324) Stanford Pediatric Psychosocial Optimization Tool for Transplant16
Molecular criteria for pulmonary antibody-mediated rejection are associated with an increased risk of allograft failure16
“Durable left ventricular assist devices as a bridge to transplantation in The Old and The New World”16
Life on the driveline: Still finding traction in improving transplant outcomes for children with myocarditis15
A rare case of late onset tacrolimus-induced leukoencephalopathy and coma after pediatric orthotopic heart transplantation15
Paucisymptomatic COVID-19 in lung transplant recipient following two doses of mRNA-1273 (Moderna) vaccine15
Dapagliflozin Use in Children with Heart Failure Undergoing Heart Transplantation15
Donor sequence number is not associated with worse lung transplant outcomes regardless of transplant center case volume15
I got it from my mamma: Sensitization by transplacental transfer of maternal HLA antibodies managed with manual exchange transfusion15
Proteomic profiling identifies CLEC4C expression as a novel biomarker of primary graft dysfunction after heart transplantation15
Risk of Prolonged Intubation Post-Pediatric Heart Transplantation15
CD38 Antibody Daratumumab as an Add-On Rescue Therapy for AMR - First Report in Clinical Lung Transplantation15
Coronavirus disease 2019 outcomes in heart transplant recipients: A large Australian cohort15
First North American Experience with The Berlin Heart Active Driver15
Towards a nuanced understanding of donor risk15
Incidence and Risk Factors for Early Stroke Following Durable Left Ventricular Assist Device (LVAD) Implantation: An STS Intermacs Analysis15
Lung Ultrasound for Diagnosis of Primary Graft Dysfunction in Lung Transplantation Recipients15
Selection of lung transplant candidates: A pediatric perspective on the International Society for Heart and Lung Transplantation consensus document14
Upfront riociguat and ambrisentan combination therapy for newly diagnosed pulmonary arterial hypertension: A prospective open-label trial14
Eplet Matching in Pediatric Heart Transplantation14
(550) A Retrospective Study on Gender, LAA Morphology and Stroke Risk14
(559) Heart Transplantation Using Super Aged Donors at 65 Years and Over14
(771) Post-Implant Outcomes in Diabetic vs. Non-Diabetic Durable LVAD Patients14
Standardized Radiographic Evaluation of Human Donor Lungs During Ex Vivo Lung Perfusion Predicts Lung Injury and Lung Transplant Outcomes14
(817) Lvad-Stem Cell Combination Therapy in Non-Ischemic Dilated Cardiomyopathy Patient: Case Report14
Artificial Intelligence for the Prognostication and Management of Heart Transplant: A Scoping Review14
Outcome-based Risk Assessment of Non-HLA Antibodies in Heart Transplantation: A Systematic Review14
Gentle Giant: An Unusual Cause of Heart Block14
VAD as Bridge to Transplant Decision in Nine-Year-Old Child with Duchenne Muscular Dystrophy14
A Rare Case of ACE Inhibitor-Induced Intestinal Angioedema Presenting as a Delayed Complication in a Heart Transplant Recipient14
(1191) Diagnostic Utility of Surveillance Transbronchial Biopsies after the First Post-Lung Transplant Year14
Study of angiogenic cell therapy for progressive pulmonary arterial hypertension: intervention with repeat dosing of eNOS-enhanced EPCs: the SAPPHIRE trial14
Rapid progression of cardiac remodeling and apical wall thinning in early age with hypertrophic cardiomyopathy14
The Role of Anti-Thymocyte Globulin in Peri-Operative Desensitization for Donor Specific Antibody Positive Lung Transplants14
The United States Experience of Lung Transplantation in Recipients with COVID-19 Fibrosis: A UNOS/OPTN Analysis14
Peri-Operative Warfarin Protocol to Decrease Length of Stay After Left Ventricular Assist Device Implantation14
Development of De-Novo Aortic Insufficiency in Patients with Durable Left Ventricular Assist Device Who Were Bridged from Impella Device14
Care Close to Home: Justification for a Second Paediatric Heart Transplant Centre in Australia14
(647) Utilization of Hepatitis C Virus Infected Donor in Heart Transplant Recipients with Elevated Meld-Xi Score13
(612) Using the SCAI Classification for Early Identification and Real-Time Monitoring of Cardiogenic Shock Patients13
(634) Is Off-Pump Coronary Bypass Surgery the Savior of Low EF Coronary Artery Disease Patients?13
Body Mass Index and Cause-Specific Mortality After Lung Transplantation in the United States13
(859) Concurrent Tracheobronchoplasty and Bilateral Lung Transplant for Obstructive Lung Disease13
(921) Effect of Surgical Exposure on Short-Term Outcomes after Bilateral Lung Transplantation13
(686) West Nile Virus Meningoencephalitis in a Bilateral Lung Transplant Recipient13
Scimitar Syndrome Outcomes in Patients with Pulmonary Hypertension: A Single Center Experience13
Low AlloSure® in HeartCare® Associated with Low Risk of Significant Allograft Rejection: An Analysis of SHORE13
(730) Continuous Temperature Measurements in Donor Hearts During Cold Organ Procurement13
Longitudinal Echocardiographic Assessment of Donor Hearts in DCD Donors Using Thoracoabdominal Normothermic Regional Perfusion13
PET Scan for CAV Screening in Heart Transplant Patients: A Real World Experience13
Risks and Outcomes Associated with Pleural Space Infections After Lung Transplantation13
Pulmonary Dead Space Fraction: A Predictive Factor for Transplant Suitability in Clinical Ex Vivo Lung Perfusion13
(826) Dual VADs to Dual Organs: Successful Bridge to Heart and Kidney Transplantation with 2 HeartMate 3 LVADs in Biventricular Failure13
Outcomes of Mechanical Circulatory Support for Severe Primary Graft Dysfunction After DBD versus DCD Heart Transplantation13
(691) Right Heart Recovery after Lung Transplantation in Patients with COVID-19-Associated Acute Respiratory Distress Syndrome: A Cohort Study13
Long-Term Weaning of Mechanical Ventilation After Lung Transplantation: Patient Characteristics and Impact on Survival13
(916) Lung Transplant Outcomes in Young Adults with Pulmonary Hypertension Bridged with ECMO13
(711) Capillary Leak Syndrome Induced by Tacrolimus in Post-Lung Transplant Recipient13
(179) Clinical Predictors of 5-year Outcomes Following Heartmate 3 Left Ventricular Assist Device Implant: The Momentum 3 Trial12
Pulmonary Artery Pressures During Cardiopulmonary Exercise Testing Using Cardiomems12
Small Anastomotic Dehiscence Identified Late After Lung Transplant12
(1246) Novel Regional Ventilation Evaluation of Abnormalities of the Lung In Advanced Lung Disease (REVEAL Study)12
Using mTOR Inhibitor Nanoimmunotherapy to Induce Cardiac Allograft Tolerance in Non-Human Primates12
(933) Mechanical Circulatory Support as a Weaning Platform from Extracorporeal Membrane Oxygenation12
(1272) Effect of Aging on the Progression of Pulmonary Ischemia-Reperfusion Injury in Clawn Miniature Swine12
(439) Severe Biventricular Dysfunction Following Pericardiectomy in a Pediatric Patient12
(1013) The Dilemma of the Role of Non-HLA Antibodies in AMR12
Proposal for Simplified Endoscopic Standardized Grading of Central Airway Complications After Lung Transplantation According to the Long-Term Prognosis Value of the Current MDS Classification12
Intercostal Nerve Cryoablation as Part of an Opioid-Sparing Protocol Reduces Narcotic and Epidural Use After Lung Transplant12
(1247) Rapidly Declining Rates of Single Lung Transplant for COPD and ILD in the U.S12
(158) Association of SIPAT Score with Long-Term Psychosocial and Clinical Outcomes in Orthotopic Heart Transplant Recipients12
Youth Perspectives on Life and Healthcare After Lung Transplant12
(1014) Super Accelerated Cardiac Allograft Vasculopathy12
Donor and Peri-Transplant Hospitalization Risk Factors for Invasive Fungal Infection in Lung Transplant Recipients12
(956) Chronic in Vivo Animal Data on a Wireless Systolic Synchronized Mini-Cardiac Pump12
(162) A Multicenter Randomized Placebo-Controlled Trial of Intravenous Thyroxine for Heart-Eligible Brain-Dead Organ Donors12
TOC - CMYK color build of red11
Clinician Assessed Versus Objective Measures of Frailty in Left Ventricular Assist Device Patients11
Intravascular Volume Derangement and Value of Blood Volume Analysis in Stable Ambulatory Patients with Advanced Heart Failure Supported with Left Ventricular Assist Device11
Donation After Circulatory Death Heart Transplantation with Ex-Vivo Perfusion: Is It Ready for Prime Time?11
Triheptanoin Use for Severe Neonatal Cardiomyopathy Secondary to Mitochondrial Trifunctional Protein Deficiency- A First Report11
(1116) Pediatric Heart Failure Program Development-Evaluation of a Single Center Experience11
0.066078901290894